Kingsway Financial Services Inc. — 2022 Form 10-K
Reporting period: Fiscal year ended December 31, 2022. Kingsway is a U.S.-focused holding company operating in extended warranties and business services through its Extended Warranty and Kingsway Search Xcelerator segments. Real estate operations were classified as discontinued operations.
Financial performance and liquidity
| Metric | 2022 | 2021 |
|---|---|---|
| Revenue | $93.3 million | $78.4 million |
| Segment operating income | $13.4 million | $13.1 million |
| Operating loss | $(3.6) million | $(0.5) million |
| Income (loss) from continuing operations | $30.1 million | $(2.7) million |
| Net income | $15.1 million | $1.9 million |
| Net income (loss) attributable to common shareholders | $24.4 million | $(0.8) million |
| Basic / diluted EPS attributable to common shareholders | $1.06 / $0.98 | $(0.04) / $(0.04) |
| Cash from continuing operating activities | $(2.6) million | $6.5 million |
Revenue increased approximately 19%. Extended Warranty revenue was $74.0 million, down slightly from $74.9 million; segment operating income fell to $9.9 million from $12.6 million. Search Xcelerator revenue rose to $19.2 million from $3.5 million and operating income to $3.5 million from $0.5 million, reflecting a full year of Ravix and the late-2022 acquisitions of CSuite and SNS. Segment operating income is a non-GAAP measure; the filing does not present consolidated operating margins as a headline measure.
Reported continuing-operations income was substantially affected by non-operating and transaction items, including a $37.9 million gain on the PWSC sale and a $16.7 million fair-value gain on trust-preferred debt repurchase options. The company also recorded $4.9 million of debt fair-value loss, $8.1 million of interest expense, and $4.8 million of income tax expense. Discontinued real estate operations contributed a $12.8 million after-tax loss, and disposal of discontinued operations added a $2.3 million after-tax loss.
At year-end, cash and cash equivalents were $64.2 million, restricted cash $13.1 million, and investments $56.9 million. Total assets were $285.7 million and shareholders’ equity $16.1 million. Principal debt was $125.3 million: $90.5 million of trust-preferred subordinated debt and $34.8 million of bank loans. Deferred trust-preferred interest was $25.5 million; the subordinated debt’s carrying value was $67.8 million because it is recorded at fair value.
Cash from continuing investing activities was $58.1 million, including net proceeds of $35.2 million from the PWSC sale, $26.4 million from the CMC property sale, and $12.2 million from real estate investment sales, partly offset by acquisitions and investment purchases. Continuing financing activities used $5.6 million. Holding-company cash was $48.9 million, compared with $2.2 million a year earlier; much of the increase reflected asset-sale proceeds. Restricted cash is not freely available and includes funds supporting warranty claims and other obligations.
Material changes and unusual items
- PWSC was sold on July 29, 2022 for a stated base purchase price of $51.2 million, generating a $37.9 million gain. An additional earnout may be payable to the sellers if specified post-sale EBITDA targets are exceeded; Kingsway said it could not reasonably estimate that amount.
- The CMC Texas property sale closed December 29, 2022 for $44.5 million cash plus assumption of approximately $170.7 million of mortgages; reported net cash proceeds to Kingsway were $21.4 million after taxes, fees, and minority distribution. VA Lafayette was classified as held for sale at year-end.
- Kingsway acquired CSuite for approximately $8.5 million cash, with up to $3.6 million of contingent consideration, and acquired SNS for $11.5 million cash. Both acquisitions were included in Search Xcelerator from their respective November closing dates.
- Interest expense increased year over year amid higher variable rates. Management estimates that a 100-basis-point increase in LIBOR, SOFR, or prime rates would increase annual interest expense by approximately $1.4 million.
- Fixed maturities had $2.5 million of gross unrealized losses at year-end; management considered the losses temporary and reported no other-than-temporary impairment write-downs for the period.
Outlook, risks, and contingencies
Management stated that available cash, investments, and anticipated operating cash flows should cover working capital and operating needs for the next 12 months, including contemplated debt and preferred-stock payments, subject to macroeconomic and other risks. This assessment included expected inflows of $8.3 million from a Net Lease property sale, $3.7 million from warrant exercises through February 2023, and a $1.5 million Amigo distribution. It also identified significant expected outflows: $56.5 million for planned trust-preferred repurchases and approximately $4.7 million of deferred interest to the remaining trust, with up to $6.1 million potentially needed to redeem Class A preferred shares. The filing describes the repurchase and redemption as intended or anticipated after year-end, not as completed at December 31, 2022. A subsequent amendment also made up to $10 million of delayed-draw borrowing available under the KWH loan.
- Debt and liquidity: Variable-rate debt, substantial deferred interest, debt covenants, and limits on subsidiary distributions constrain financial flexibility. Trust-preferred interest had been deferred since 2018; the debt agreements permit deferral for up to 20 quarters. The company said it intended to repurchase specified securities by March 15, 2023, leaving $15 million principal outstanding, and to pay interest to the remaining holder.
- Internal controls: Management concluded disclosure controls and internal control over financial reporting were not effective at year-end because of one unremediated material weakness concerning complex, nonrecurring transactions and application of ASC 606 revenue guidance. Management was developing a remediation plan; the external auditor did not audit internal-control effectiveness.
- Taxes: U.S. net operating loss carryforwards were approximately $644.2 million, but their use depends on future taxable income and may be limited by ownership changes under Section 382. A $130.6 million valuation allowance was recorded against deferred tax assets.
- Claims and legal exposures: Under a settlement with Aegis, Kingsway may owe 60% of future covered customs-bond losses, subject to a $4.8 million maximum; future timing and severity were not reasonably determinable. A $2.5 million Mendota indemnity liability was recorded, and $2.0 million previously escrowed was remitted to the buyer in the first quarter of 2023. Ordinary-course litigation losses were not estimable.
- Operating risks: Risks include warranty claims and deferred-fee estimation, vehicle sales and dealer/credit-union relationships, acquisition integration, investment-market volatility, and competition. SNS additionally faces nurse recruitment, wage/billing spread, and healthcare regulatory risks; Ravix and CSuite have exposure to venture-capital funding and M&A activity.
- Other conditions: The filing cites the continuing effects of COVID-19, inflation, recession risk, supply-chain disruption, and geopolitical uncertainty. It also notes possible NYSE listing compliance risk and that the company had not declared a dividend since 2009.
Key facts for investors to verify
- Whether the planned trust-preferred repurchase and preferred-share conversion or redemption were completed, and the resulting cash balance, debt, deferred interest, and share count.
- Whether management remediated the ASC 606 material weakness and whether any subsequent filings identify control deficiencies or revenue adjustments.
- Actual performance and integration of CSuite and SNS, including contingent consideration and acquisition-related borrowing.
- Cash available at the holding company versus restricted or subsidiary-level cash, and compliance with debt covenants and distribution limits.
- Use and potential Section 382 limitations on the $644.2 million of U.S. NOLs, as well as any changes to the valuation allowance.
- Resolution of the Aegis settlement exposure, Mendota indemnity, PWSC earnout, and VA Lafayette sale.